Zivo Bioscience, Inc. financial data

Symbol
ZIVO, ZIVOW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
21 E. Long Lake Road, Suite 100, Bloomfield Hills, MI
State of incorporation
NV
Fiscal year end
December 31
Former names
HEALTH ENHANCEMENT PRODUCTS INC (to 10/16/2014), WESTERN GLORY HOLE INC (to 1/26/2004)
Latest financial report
10-K - Q4 2024 - Mar 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31 % +1.34%
Debt-to-equity -149 % +3.63%
Return On Assets -1.52K % -119%
Operating Margin -8.5K % +67.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.76M shares +35.3%
Common Stock, Shares, Outstanding 3.62M shares +52%
Entity Public Float 15.6M USD -9.83%
Common Stock, Value, Issued 3.62K USD +52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 157K USD +469%
Revenue from Contract with Customer, Excluding Assessed Tax 157K USD +469%
Research and Development Expense 3.13M USD +128%
General and Administrative Expense 10.3M USD +74.2%
Operating Income (Loss) -13.4M USD -84%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -13.4M USD -72.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 1.64M USD +284%
Property, Plant and Equipment, Net 0 USD
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 1.64M USD +196%
Accounts Payable, Current 547K USD -44.9%
Accrued Liabilities, Current 1.1M USD -4.58%
Liabilities, Current 2.04M USD -26.1%
Operating Lease, Liability, Noncurrent 116K USD
Liabilities 2.16M USD -21.9%
Retained Earnings (Accumulated Deficit) -137M USD -10.8%
Stockholders' Equity Attributable to Parent -515K USD +76.7%
Liabilities and Equity 1.64M USD +196%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.7M USD +20.2%
Net Cash Provided by (Used in) Financing Activities 1.56M USD +190%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 25M shares +900%
Common Stock, Shares, Issued 3.62M shares +52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.54M USD +462%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.06K USD -13.5%
Deferred Tax Assets, Valuation Allowance 13.7M USD +10.9%
Operating Lease, Liability 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 142K USD
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 112K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 29.5K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.47K USD -68.1%
Preferred Stock, Shares Issued 3.49M shares +100%
Additional Paid in Capital 136M USD +12.4%
Deferred Tax Assets, Net of Valuation Allowance 13.7M USD +10.9%
Interest Expense -25.7K USD -136%